Invention Grant
- Patent Title: Haemocoagulase
-
Application No.: US12952308Application Date: 2010-11-23
-
Publication No.: US08017750B2Publication Date: 2011-09-13
- Inventor: Xijuan Wang
- Applicant: Xijuan Wang
- Applicant Address: CN Beijing
- Assignee: Konruns Pharmaceutical Co., Ltd
- Current Assignee: Konruns Pharmaceutical Co., Ltd
- Current Assignee Address: CN Beijing
- Agency: Workman Nydegger
- Priority: CN200610150566 20061019
- Main IPC: C12N9/00
- IPC: C12N9/00 ; C07H21/04

Abstract:
The present invention provides a venene haemocoagulase gene and its expression for the functional protein. The haemocoagulase gene of the present invention has a nucleotide sequence shown by the sequence list SEQ ID NO: 1 or the mutated nucleotide sequence formed by replacement, depletion, or addition of one or more nucleotide based on the said nucleotide sequence with an equivalent function. The said haemocoagulase has amino acid sequence shown by SEQ ID NO: 2. Haemocoagulase of the present invention has an obvious hemostatic effect, a broad effective dose range, safe and reliable application, which creates good conditions for the development of genetic engineering products of recombinant haemocoagulase in the future.
Public/Granted literature
- US20110071283A1 HAEMOCOAGULASE Public/Granted day:2011-03-24
Information query